Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKKVL.L Regulatory News (KKVL)

  • There is currently no data for KKVL

Valuation Update

30 Sep 2020 15:49

RNS Number : 6532A
KKV Secured Loan Fund Limited
30 September 2020
 

30 September 2020

KKV Secured Loan Fund Limited

 

LEI: 2138007S3YRY3IUU4W39

 

Valuation Update

 

The Board of KKV Secured Loan Fund Limited (the "Company") today provides an update in respect of the valuation of the Company's portfolios.

 

The Company released an announcement on 6 August 2020, in which it stated that KKV Investment Management Limited (the "Portfolio Manager") had identified concerns regarding the valuation of certain assets in the portfolios of the Ordinary and C Share Classes of the Company. At that time, the Company stated that the Portfolio Manager had identified assets representing c.£54m* of the NAV of the Ordinary Shares and c.£4m* of the NAV of the C Shares that it believed required further review with the assistance of an independent third-party, and that additional assets may also be affected.

 

The Portfolio Manager has advised the Board that, follow further analysis, it is proposing that assets representing a total of £94m* of the NAV of the Ordinary Shares and c.£51m* of the NAV of the C Shares be reviewed with the assistance of an independent third-party. This excludes the Company's Anaerobic Digestion assets which are, as previously disclosed, subject to a separate review process for the year-ended 30 June 2020.

 

The NAV as at 30 June 2020 reflected the Portfolio Manager's initial estimate of impairments and, given the uncertainties, the Board decided to seek additional support for the Portfolio Manager to review specific assets, provide assurance on investment values and confirm the need for any further material impairments. While an independent third-party will be used to assist with the review of these assets, it is not necessarily the case that all such assets will require material impairment. The Portfolio Manager's review will continue to run in parallel and it is likely that assets not part of independent third-party exercise may also require impairment.

 

\* The asset values quoted above are based upon the valuation attributed to such assets in the estimated unaudited NAV as at 30 June 2020, announced on 24 July 2020 (being the last published NAV). As previously stated, such assets are likely to be subject to impairment which will be reflected in the Company's report and accounts for the year-ended 30 June 2020.

 

The Company has appointed KPMG LLP ("KPMG") to assist the Board with its ongoing review, although additional third-party specialists may be appointed if appropriate. KPMG has commenced its work and will complete this in advance of the publication of the Company's annual report and accounts for the year-ended 30 June 2020, expected to be announced prior to the end of 2020. A further update will be provided as soon as additional material information is available.

 

At 30 June 2020 there was an amount of £2.15m that is due from the Ordinary Share class to the C Share class. It is intended that this amount will be repaid as soon as possible.

 

This announcement is released by KKV Secured Loan Fund Limited and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

For further information please contact:

 

KKV Investment Management Ltd

Catherine Halford Riera

Nicola Bird

 

020 7429 2200

 

BNP Paribas Securities Services S.C.A., Guernsey Branch

Company Secretary

 

01481 750 853

 

Winterflood Securities Limited

Neil Langford

 

 

020 3100 0000

 

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, the person responsible for releasing this announcement is Sharon Williams, Company Secretary.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUZBLFXBKLZBBV
12
Date   Source Headline
1st Dec 20211:20 pmRNSChange of Name
29th Nov 20213:57 pmRNSResult of AGM
22nd Nov 20218:00 amRNSIncentive Arrangements – Proposed Amendments
17th Nov 20217:00 amRNSAnnual Financial Report
10th Nov 20212:46 pmRNSHolding(s) in Company
5th Nov 20214:41 pmRNSSecond Price Monitoring Extn
5th Nov 20214:36 pmRNSPrice Monitoring Extension
1st Nov 20214:45 pmRNSNotice of AGM
26th Oct 20214:40 pmRNSSecond Price Monitoring Extn
26th Oct 20214:36 pmRNSPrice Monitoring Extension
21st Oct 20212:00 pmRNSPortfolio Manager Update
8th Oct 20214:40 pmRNSSecond Price Monitoring Extn
8th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:36 pmRNSPrice Monitoring Extension
6th Oct 20219:34 amRNSUpdate on Assets
23rd Sep 20214:41 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:36 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSTotal Voting Rights
20th Aug 20217:00 amRNSAmendment and Termination of IMA
18th Aug 202110:28 amRNSReturn of Capital
9th Aug 202112:04 pmRNSUpdate of Assets
4th Aug 20218:59 amRNSUpdate on Assets
23rd Jul 20214:40 pmRNSSecond Price Monitoring Extn
23rd Jul 20214:35 pmRNSPrice Monitoring Extension
7th Jul 20217:00 amRNSReturn of Capital
5th Jul 20217:00 amRNSPortfolio Manager Update
25th Jun 20214:50 pmRNSPortfolio Manager Update
21st Jun 20214:41 pmRNSSecond Price Monitoring Extn
21st Jun 20214:35 pmRNSPrice Monitoring Extension
11th Jun 20214:41 pmRNSSecond Price Monitoring Extn
11th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20213:10 pmRNSUpdate on Assets
21st May 202112:58 pmRNSNet Asset Value(s)
11th May 20213:00 pmRNSPortfolio Manager Update
26th Apr 20219:51 amRNSDirector/PDMR Shareholding
23rd Apr 20217:00 amRNSHalf-year Report
21st Apr 202110:07 amRNSHolding(s) in Company
9th Apr 20212:51 pmRNSReturn of Capital
8th Apr 20214:40 pmRNSSecond Price Monitoring Extn
8th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:15 pmRNSAGM Results Update Statement
23rd Mar 202110:57 amRNSSale of AD Plant Assets
22nd Mar 20217:00 amRNSSale of Assets
5th Mar 20214:36 pmRNSPrice Monitoring Extension
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
25th Feb 20217:00 amRNSChange in Management Fee Arrangements
24th Feb 20214:35 pmRNSReturn of Capital
24th Feb 20212:27 pmRNSDirectorate Change
18th Feb 20217:00 amRNSBuy-back of Investment & NAV positive impact
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.